SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-19-000005
Filing Date
2019-05-08
Accepted
2019-05-08 16:59:26
Documents
93
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avdl2019q1.htm 10-Q 1453466
2 EXHIBIT 31.1 exhibit311q12019.htm EX-31.1 10233
3 EXHIBIT 31.2 exhibit312q12019.htm EX-31.2 10120
4 EXHIBIT 32.1 exhibit321q12019.htm EX-32.1 5611
5 EXHIBIT 32.2 exhibit322q12019.htm EX-32.2 5612
  Complete submission text file 0001012477-19-000005.txt   7707449

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avdl-20190331.xml EX-101.INS 1710846
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20190331.xsd EX-101.SCH 57416
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20190331_cal.xml EX-101.CAL 126162
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20190331_def.xml EX-101.DEF 227745
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20190331_lab.xml EX-101.LAB 709861
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20190331_pre.xml EX-101.PRE 420214
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 19807451
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences